You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Melanoma Milestones: Expert Insights on Current and Emerging Treatment Strategies Across the Disease

  • Authors: John M. Kirkwood, MD; Vishal A. Patel, MD
  • CME / ABIM MOC Released: 12/9/2022
  • Valid for credit through: 12/9/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.75 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for dermatologists, surgeons, and other members of the multidisciplinary team.

The goal of this activity is that learners will be better able to understand current and emerging treatment strategies being evaluated across the spectrum of melanoma and how these strategies impact the multidisciplinary management of these patients.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Key clinical trial data evaluating targeted therapies for the treatment of patients with melanoma
  • Have greater competence related to
    • Tailoring treatment strategies for patients with melanoma
  • Demonstrate greater confidence in their ability to
    • Collaborate with the multidisciplinary team to optimize care for patients with melanoma


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • John M. Kirkwood, MD

    Distinguished Service Professor of Medicine
    University of Pittsburgh School of Medicine
    Co-Director, Melanoma and Skin Cancer Program
    UPMC Hillman Cancer Center
    Pittsburgh, Pennsylvania

    Disclosures

    John M. Kirkwood, MD, has the following relevant financial relationships:
    Consultant or advisor for: Applied Clinical Intelligence, LLC; Amgen, Inc.; Ankyra Therapeutics; Axio Research / Instil Bio; Becker Pharmaceutical Consulting; Bristol Myers Squibb; Checkmate Pharmaceuticals; DermTech; Fenix Group International; Harbour BioMed; Immunocore LLC; Intellisphere, LLC / Cancer Network; Iovance Biotherapeutics IQVIA; Istari Oncology; Merck; Millennium Pharmaceuticals / Takeda Pharmaceutical; Natera Inc.; Novartis Pharmaceuticals; OncoCyte Corporation; OncoSec Medical Inc.; Pfizer; Replimune; Scopus BioPharma; SR One Capital Management
    Research funding from: Amgen Inc.; Bristol Myers Squibb; Castle Biosciences, Inc.; Checkmate Pharmaceuticals; Harbour BioMed; Immvira Pharma Co.; Immunocore LLC; Iovance Biotherapeutics; Merck; Novartis Pharmaceuticals; Schering-Plough; Takeda; Verastem, Inc.

  • Vishal A. Patel, MD

    Associate Professor of Dermatology
    Associate Professor of Medicine, Oncology
    Director of Cutaneous Oncology, Director of Dermatologic Surgery
    George Washington University School of Medicine
    Washington, DC

    Disclosures

    Vishal A. Patel, MD, has the following relevant financial relationships:
    Consultant or advisor for: Almirall; Jounce Therapeutics; PhD Biosciences
    Speaker or member of speakers bureau for: Regeneron; Sanofi
    Stock options from: Lazarus Inc.
    Owns stock (publicly traded) in: Science 37, Inc.

Editor

  • Lisa Cockrell, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Lisa Cockrell, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Lisa Simani, APRN, MS, ACNP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Melanoma Milestones: Expert Insights on Current and Emerging Treatment Strategies Across the Disease

Authors: John M. Kirkwood, MD; Vishal A. Patel, MDFaculty and Disclosures

CME / ABIM MOC Released: 12/9/2022

Valid for credit through: 12/9/2023

processing....

Learning Feedback Questions

Please answer these questions to complement your learning experience.

  • Print